Ming Zong
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Nanoplatforms for cancer theranostics 6
- Biosensors and Analytical Detection 3
- Co-authors
- Lieying Fan (26 shared papers)Chen Suo (2 shared papers)Qiuhong Man (2 shared papers)Ying Lü (6 shared papers)Shanshan Yu (7 shared papers)Zhenqiu Liu (1 shared paper)Tianbao Lu (5 shared papers)Min Ge (7 shared papers)
In The Last Decade
Ming Zong
69 papers receiving 1.2k citations
Ming Zong's Hit Papers
Peers
Comparison fields: 5 of 114
- Rheumatology 164
- Cancer Research 124
- Biophysics 40
- Immunology 115
- Neurology 39
Countries citing papers authored by Ming Zong
This map shows the geographic impact of Ming Zong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Zong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Zong more than expected).
Fields of papers citing papers by Ming Zong
This network shows the impact of papers produced by Ming Zong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Zong. The network helps show where Ming Zong may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Zong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global Burden, Risk Factor Analysis, and Prediction Study of Ischemic Stroke, 1990–2030 Hit paper breakdown → | 2023 | 204 |
| 2 | 2022 | 71 | |
| 3 | 2017 | 48 | |
| 4 | 2012 | 45 | |
| 5 | 2021 | 40 | |
| 6 | 2012 | 40 | |
| 7 | 2023 | 38 | |
| 8 | 2015 | 38 | |
| 9 | 2014 | 34 | |
| 10 | 2022 | 33 | |
| 11 | 2020 | 33 | |
| 12 | 2019 | 31 | |
| 13 | 2008 | 29 | |
| 14 | 2021 | 26 | |
| 15 | 2020 | 24 | |
| 16 | 2010 | 24 | |
| 17 | 2009 | 21 | |
| 18 | 2020 | 19 | |
| 19 | 2022 | 19 | |
| 20 | 2010 | 19 |
About Ming Zong
Ming Zong is a scholar working on Molecular Biology, Biomedical Engineering, Surgery, Immunology and Materials Chemistry, having authored 70 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (6 papers), Advanced Photocatalysis Techniques (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Inflammatory mediators and NSAID effects (4 papers), MXene and MAX Phase Materials (4 papers), MicroRNA in disease regulation (4 papers), Biosensors and Analytical Detection (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). The work is most often cited by research in Rheumatology (164 citations), Cancer Research (124 citations), Biophysics (40 citations), Immunology (115 citations) and Neurology (39 citations). Ming Zong has collaborated with scholars based in China, Canada and Hong Kong. Frequent co-authors include Lieying Fan, Chen Suo, Qiuhong Man, Ying Lü, Shanshan Yu, Zhenqiu Liu, Tianbao Lu, Min Ge, Shasha Fan and Han Lin. Their work appears in journals such as Arthritis Research & Therapy, Journal of Clinical Laboratory Analysis, Clinica Chimica Acta, Scientific Reports and Theriogenology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.